{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:02:47Z","timestamp":1792105367219,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Medications are commonly used for symptom control in cancer patients at the end of life. This study aimed to evaluate medication utilization among home care palliative patients with cancer at the end of life and assess the appropriateness of these medications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This retrospective observational study included adult cancer patients who received home care in 2020. Medications taken during the last month of the patient\u2019s life were reviewed and classified into three major categories: potentially avoidable, defined as medications that usually have no place at the end of life because the time to benefit is shorter than life expectancy; medications of uncertain appropriateness, defined as medications that need case-by-case evaluation because they could have a role at the end of life; and potentially appropriate, defined as medications that provide symptomatic relief.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In our study, we enrolled 353 patients, and 2707 medications were analyzed for appropriateness. Among those, 1712 (63.2%) were classified as potentially appropriate, 755 (27.9%) as potentially avoidable, and 240 (8.9%) as medications with uncertain appropriateness. The most common potentially avoidable medications were medications for peptic ulcers and gastroesophageal reflux disease (30.5%), vitamins (14.6%), beta-blockers (9.8%), anticoagulants (7.9%), oral antidiabetics (5.4%) and insulin products (5.3%). Among the potentially appropriate medications, opioid analgesics were the most frequently utilized medications (19.5%), followed by laxatives (19%), nonopioid analgesics (14.4%), gamma-aminobutyric acid analog analgesics (7.7%) and systemic corticosteroids (6%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In home care cancer patients, approximately one-third of prescribed medications were considered potentially avoidable. Future measures to optimize medication use in this patient population are essential.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-024-01432-4","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T08:02:14Z","timestamp":1714118534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Appropriate use of medication among home care adult cancer patients at end of life: a retrospective observational study"],"prefix":"10.1186","volume":"23","author":[{"given":"Amani El","family":"Mughrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewar S.","family":"Salmany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Aljarrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala\u2019a","family":"Dabbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Ayyalawwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"1432_CR1","unstructured":"World Health Organization (WHO). Palliative care.2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care. Accessed 29 March 2023."},{"key":"1432_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216313517283","author":"M Riolfi","year":"2014","unstructured":"Riolfi M, Buja A, Zanardo C, Marangon CF, Manno P, Baldo V. Effectiveness of palliative home-care services in reducing hospital admissions and determinants of hospitalization for terminally ill patients followed up by a palliative home-care team: a retrospective cohort study. Palliat Med. 2014. https:\/\/doi.org\/10.1177\/0269216313517283.","journal-title":"Palliat Med"},{"key":"1432_CR3","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2014.0150","author":"CY Chen","year":"2015","unstructured":"Chen CY, Thorsteinsdottir B, Cha SS, et al. Health care outcomes and advance care planning in older adults who receive home-based palliative care: a pilot cohort study. J Palliat Med. 2015. https:\/\/doi.org\/10.1089\/jpm.2014.0150.","journal-title":"J Palliat Med"},{"key":"1432_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007760.pub2","author":"B Gomes","year":"2013","unstructured":"Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD007760.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1432_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr059","author":"D O\u2019Mahony","year":"2011","unstructured":"O\u2019Mahony D, O\u2019Connor MN. Pharmacotherapy at the end-of-life. Age Ageing. 2011. https:\/\/doi.org\/10.1093\/ageing\/afr059.","journal-title":"Age Ageing"},{"key":"1432_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0541-y","author":"RP Riechelmann","year":"2009","unstructured":"Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer. 2009. https:\/\/doi.org\/10.1007\/s00520-008-0541-y.","journal-title":"Support Care Cancer"},{"key":"1432_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.6.605","author":"HM Holmes","year":"2006","unstructured":"Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006. https:\/\/doi.org\/10.1001\/archinte.166.6.605.","journal-title":"Arch Intern Med"},{"key":"1432_CR8","doi-asserted-by":"publisher","DOI":"10.2165\/11631740-000000000-00000","author":"AJ Cruz-Jentoft","year":"2012","unstructured":"Cruz-Jentoft AJ, Boland B, Rexach L. Drug therapy optimization at the end of life. Drugs Aging. 2012. https:\/\/doi.org\/10.2165\/11631740-000000000-00000.","journal-title":"Drugs Aging"},{"key":"1432_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1921","author":"DM Blass","year":"2008","unstructured":"Blass DM, Black BS, Phillips H, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008. https:\/\/doi.org\/10.1002\/gps.1921.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1432_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-020-00315-0","author":"L Pasina","year":"2020","unstructured":"Pasina L, Recchia A, Nobili A, Rizzi B. Inappropriate medications among end-of-life patients living at home: an Italian observational study. Eur Geriatr Med. 2020. https:\/\/doi.org\/10.1007\/s41999-020-00315-0.","journal-title":"Eur Geriatr Med"},{"key":"1432_CR11","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2018.0559","author":"A Wenedy","year":"2019","unstructured":"Wenedy A, Lim YQ, Lin Ronggui CK, Koh GCH, Chong PH, Chew LST. A study of Medication Use of Cancer and Non-cancer patients in Home Hospice Care in Singapore: a retrospective study from 2011 to 2015. J Palliat Med. 2019. https:\/\/doi.org\/10.1089\/jpm.2018.0559.","journal-title":"J Palliat Med"},{"key":"1432_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1049909118794926","author":"L Pasina","year":"2019","unstructured":"Pasina L, Recchia A, Agosti P, Nobili A, Rizzi B. Prevalence of preventive and symptomatic drug treatments in Hospice Care: an Italian observational study. Am J Hosp Palliat Care. 2019. https:\/\/doi.org\/10.1177\/1049909118794926.","journal-title":"Am J Hosp Palliat Care"},{"key":"1432_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/1049909113476132","author":"L Sera","year":"2014","unstructured":"Sera L, McPherson ML, Holmes HM. Commonly prescribed medications in a population of hospice patients. Am J Hosp Palliat Care. 2014. https:\/\/doi.org\/10.1177\/1049909113476132.","journal-title":"Am J Hosp Palliat Care"},{"key":"1432_CR14","doi-asserted-by":"publisher","DOI":"10.1179\/174329111X576698","author":"AR Maddison","year":"2011","unstructured":"Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011. https:\/\/doi.org\/10.1179\/174329111X576698.","journal-title":"Prog Palliat Care"},{"key":"1432_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-017-0487-1","author":"SW Narayan","year":"2017","unstructured":"Narayan SW, Nishtala PS. Discontinuation of Preventive Medicines in Older people with Limited Life Expectancy: a systematic review. Drugs Aging. 2017. https:\/\/doi.org\/10.1007\/s40266-017-0487-1.","journal-title":"Drugs Aging"},{"key":"1432_CR16","doi-asserted-by":"publisher","DOI":"10.1300\/j354v21n03_05","author":"L De Lima","year":"2007","unstructured":"De Lima L, Doyle D. The International Association for Hospice and Palliative Care list of essential medicines for palliative care. J Pain Palliat Care Pharmacother. 2007. https:\/\/doi.org\/10.1300\/j354v21n03_05.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1432_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2322-0","author":"J Lindsay","year":"2015","unstructured":"Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019. Support Care Cancer. 2015. https:\/\/doi.org\/10.1007\/s00520-014-2322-0.","journal-title":"Support Care Cancer"},{"key":"1432_CR18","unstructured":"Up To Date. (n.d.) General drug information. https:\/\/www.uptodate.com\/contents\/table-of-contents\/drug-information\/general-drug-information. Accessed 8 September 2022."},{"key":"1432_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-020-00569-2","author":"AM Hagarty","year":"2020","unstructured":"Hagarty AM, Bush SH, Talarico R, Lapenskie J, Tanuseputro P. Severe pain at the end of life: a population-level observational study. BMC Palliat Care. 2020. https:\/\/doi.org\/10.1186\/s12904-020-00569-2.","journal-title":"BMC Palliat Care"},{"key":"1432_CR20","first-page":"6581","volume":"34","author":"L Koivu","year":"2014","unstructured":"Koivu L, P\u00f6l\u00f6nen T, Stormi T, Salminen E. End-of-life pain medication among cancer patients in hospice settings. Anticancer Res. 2014;34:6581\u20134.","journal-title":"Anticancer Res"},{"key":"1432_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/s0885-3924(97)00263-7","author":"C Conill","year":"1997","unstructured":"Conill C, Verger E, Henr\u00edquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997. https:\/\/doi.org\/10.1016\/s0885-3924(97)00263-7.","journal-title":"J Pain Symptom Manage"},{"key":"1432_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39406.449456.BE","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008. https:\/\/doi.org\/10.1136\/bmj.39406.449456.BE.","journal-title":"BMJ"},{"key":"1432_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010989","author":"SS Mortazavi","year":"2016","unstructured":"Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016. https:\/\/doi.org\/10.1136\/bmjopen-2015-010989.","journal-title":"BMJ Open"},{"key":"1432_CR24","first-page":"247","volume":"27","author":"TK Basu","year":"1985","unstructured":"Basu TK. Drug-vitamin interaction. Int J Vitam Nutr Res Suppl. 1985;27:247\u201358.","journal-title":"Int J Vitam Nutr Res Suppl"},{"key":"1432_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.12.007","author":"MB Bottorff","year":"2006","unstructured":"Bottorff MB. Statin safety and drug interactions: clinical implications. Am J Cardiol. 2006. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.007.","journal-title":"Am J Cardiol"},{"key":"1432_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-023-02049-x","author":"A Antonisse","year":"2023","unstructured":"Antonisse A, van der Baan FH, Grant M, Uyttewaal, et al. Use of preventive medication and supplements in general practice in patients in their last year of life: a retrospective cohort study. BMC Prim Care. 2023. https:\/\/doi.org\/10.1186\/s12875-023-02049-x.","journal-title":"BMC Prim Care"},{"key":"1432_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13861","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graabaek T, Ryg J, S\u00f8ndergaard J, Potteg\u00e5rd A, Nielsen DS. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol. 2019. https:\/\/doi.org\/10.1111\/bcp.13861.","journal-title":"Br J Clin Pharmacol"},{"key":"1432_CR28","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2021.3.2350","author":"N Gaurang","year":"2021","unstructured":"Gaurang N, Priyadharsini R, Balamurugesan K, Prakash M, Reka D. Attitudes and beliefs of patients and primary caregivers towards deprescribing in a tertiary health care facility. Pharm Pract (Granada). 2021. https:\/\/doi.org\/10.18549\/PharmPract.2021.3.2350.","journal-title":"Pharm Pract (Granada)"},{"key":"1432_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05827-w","author":"A Batra","year":"2021","unstructured":"Batra A, Yang L, Boyne DJ, Harper A, Cuthbert CA, Cheung WY. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study. Support Care Cancer. 2021. https:\/\/doi.org\/10.1007\/s00520-020-05827-w.","journal-title":"Support Care Cancer"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-024-01432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T08:03:48Z","timestamp":1714118628000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-024-01432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1186\/s12904-024-01432-4","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was reviewed and approved by the Institutional Review Board (IRB) of KHCC with ethics approval number 21 KHCC 066 on July 15, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}